Meeting
2024 ASCO Genitourinary Cancers Symposium
Fluorescence in situ hybridization utility in the care management of renal cell carcinoma (prospective study, 30 cases).
Authors
Rafik BEN Tayeb
Department of Pathology, Hassan Ii University Hospital, Fez, Morocco
Rafik BEN Tayeb , Mohamed Mziyene , Layla Tahiri , Laila Bouguenouch , Hinde El Fatemi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer
Sub Track
Diagnostics and Imaging
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 378)
DOI
10.1200/JCO.2024.42.4_suppl.378
Abstract #
378
Poster Bd #
F2
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Real world outcomes of patients with non-clear cell renal cell carcinoma: A single Asian centre experience.
First Author: Johan W.K. Chan
Poster
2022 ASCO Annual Meeting
Molecular characterization of the tumor microenvironment in chromophobe renal cell carcinoma (ChRCC) and related oncocytic neoplasms.
First Author: Chris Labaki
Poster
2022 ASCO Genitourinary Cancers Symposium
CD70 is a promising CAR-T cell target in patients with advanced renal cell carcinoma.
First Author: Huihui Ye
Poster
2020 ASCO Virtual Scientific Program
Comprehensive genomic profiling of 216 Chinese patients with renal cell carcinoma.
First Author: Congwang Zhang